Delivery Order SPE2DE24D0021-SPE2D626F09TZ
- Not listed
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $1,560.94 by the Department of Defense's Medical Supply Chain division for the procurement of ANDI-D Bioclone 10ML in 15-pack quantities. This fixed-price delivery order with economic price adjustment authority was awarded without set-aside designation on August 1, 2025, and is scheduled for ultimate completion by August 22, 2025. The product will be delivered to Pittsburgh, PA 15275. This delivery order represents a...
- The Department of Defense's Medical Supply Chain has awarded a delivery order valued at $1,560.94 to Fisher Scientific Company L.L.C. for ANDI-D Bioclone 10ML products (15-pack units) with an ultimate completion date of January 5, 2026. This fixed-price contract with economic price adjustment represents a child order issued under Fisher Scientific's existing indefinite delivery vehicle with the federal government. The award was made without a set-aside designation, indicating open competition,...
- Fisher Scientific Company L.L.C. received a fixed-price delivery order award from the Department of Defense's Medical Supply Chain for ANDI-D Bioclone 10ML products (15 pack units) with a ceiling value of $1,560.94. The award was issued on November 17, 2025, with an ultimate completion date of December 9, 2025. This is a child contract with no set-aside designation, awarded competitively in the open federal procurement market. The place of performance is Pittsburgh, Pennsylvania, where Fisher...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $1,560.94 for ANDI-D Bioclone 10mL 15/pack, with a ultimate completion date of December 2, 2025. This fixed-price contract with economic price adjustment was awarded on November 7, 2025, by the Defense Department's Medical Supply Chain, a federal agency responsible for procuring medical and laboratory supplies for military healthcare operations. The award carries no set-aside designation, indicating it was competitively...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,560.94 on August 11, 2025, for the procurement of ANDI-D Bioclone 10ML in 15-pack quantities. This fixed-price contract with economic price adjustment is funded by the Medical Supply Chain division of the Department of Defense and will be performed in Pittsburgh, PA, with an ultimate completion date of September 2, 2025. The award represents a child contract under a larger vehicle and was not subject to any set-aside...
- Fisher Scientific Company L.L.C. has been awarded a delivery order contract valued at $1,560.94 for the procurement of ANDI-D Bioclone 10ML 15/PK medical supplies. The contract, awarded on August 6, 2025, with an ultimate completion date of August 27, 2025, is a fixed-price delivery order with economic price adjustment provisions. This child contract is being performed in Pittsburgh, Pennsylvania, and is funded by the Defense-focused Medical Supply Chain agency within the U.S. government. No...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,560.94 on July 31, 2025, by the Defense Department's Medical Supply Chain division for ANDI-D Bioclone 10ML products (15-pack units). This fixed-price contract with economic price adjustment terms represents a child award under a larger contract vehicle and carries no set-aside designation, reflecting open competition procurement. The work will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $1,071.90 by the Department of Defense's Medical Supply Chain for an immunology test kit with rapid developer capabilities, with performance completion scheduled for December 22, 2025. This is a fixed-price contract with economic price adjustment pricing and represents a child delivery order issued under a larger indefinite delivery vehicle. The award carries no set-aside designation, indicating Fisher Scientific...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $1,124.28 under a fixed-price contract with economic price adjustment provisions by the Department of Defense's Medical Supply Chain. The order, issued on November 17, 2025, with an ultimate completion date of November 21, 2025, represents a child delivery order under a larger contract vehicle. The award carries no set-aside designation, indicating Fisher Scientific competed in an open procurement environment....
- Fisher Scientific Company L.L.C., a major federal laboratory and medical supplies vendor based in Pittsburgh, Pennsylvania, has been awarded a delivery order valued at $1,042.00 by the Department of Defense's Medical Supply Chain, with an ultimate completion date of December 26, 2025. This fixed-price delivery order with economic price adjustment carries no set-aside designation, indicating it was awarded through open competition. The award represents a child contract under a larger...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D626F09TZDelivery Order
Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,560.94 by the Department of Defense's Medical Supply Chain on January 15, 2026, for the provision of Andi-D Bioclone 10ml diagnostic products in 15-pack quantities. The contract, which operates under a fixed-price structure with economic price adjustment provisions, is a child delivery order issued against a larger indefinite delivery vehicle and carries an ultimate completion date of February 6, 2026. No set-aside designation was applied to this procurement, indicating open competition. The place of performance is Pittsburgh, Pennsylvania, where Fisher Scientific maintains its principal business location. This award reflects Fisher Scientific's established role as a critical supplier of laboratory and medical diagnostic equipment to the Department of Defense Medical Supply Chain. The company's extensive federal contracting history demonstrates consistent success in delivering specialized laboratory reagents, diagnostic test kits, and medical supplies across multiple government agencies, including the Department of Veterans Affairs and civilian health institutes. The modest delivery order value and compressed performance timeline indicate this represents routine consumable procurement supporting ongoing diagnostic operations within the Defense Medical Supply Chain's laboratory and healthcare delivery infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 1/14/26 |